Skip to main content
Fig. 3 | Journal of Hematology & Oncology

Fig. 3

From: Allogeneic stem cell transplantation in adult patients with acute myeloid leukaemia and 17p abnormalities in first complete remission: a study from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)

Fig. 3

Overall survival (OS) (a) and leukaemia-free survival (LFS) (b). In the whole cohort, the 2-year probability of OS was 28% [95% CI 19.7–37.1] (a) and the 2-year probability of LFS was 24% [95% CI 15.7–31.9] (b)

Back to article page